摘要
目的对糖尿病周围神经病变临床治疗中前列地尔联合甲钴胺疗效展开研究。方法 2017年6月-2018年12月间随机选择100例糖尿病周围神经病变患者开展分组研究。对照组给予前列地尔,实验组此基础上联合甲钴胺,疗程均为2周。结果实验组在总有效率、SNCV与MNCV评分以及临床症状评分中前两者高于对照组,而后者则小于其。结论针对糖尿病周围神经病变临床治疗上前列地尔联合甲钴胺不但能够获取良好联系,且对于患者症状有效减轻发挥着积极作用。
Objective To study the efficacy of alprostadil combined with mecobalamin in the clinical treatment of diabetic peripheral neuropathy. Methods From June 2017 to December 2018 a randomized study of 100 patients with diabetic peripheral neuropathy was conducted. The control group was given alprostadil, and the experimental group was combined with mecobalamin for 2 weeks. Results The first two of the experimental group were higher than the control group in terms of total effective rate, SNCV and MNCV scores, and clinical symptom scores, while the latter was smaller than the control group. Conclusion For the treatment of diabetic peripheral neuropathy, alprostadil combined with mecobalamin can not only obtain good contact, but also play an active role in the effective reduction of symptoms.
作者
谭丽娜
TAN Li-na(Department of Internal Medicine, the First Affiliated Hospital of Qihar Medical College, Qiqihar, Heilongjiang Province,161000 China)
出处
《糖尿病新世界》
2019年第17期191-192,共2页
Diabetes New World Magazine
关键词
糖尿病周围神经病变
前列地尔
甲钴胺
疗效观察
Diabetic peripheral neuropathy
Alprostadil
Mecobalamin
Therapeutic effect